| 商品名 | 申请号 | 产品号 | 申请类型 | 活性成分 | 剂型/给药途径 | 规格/剂量 | RLD | RS | 申请号原始批准/暂定批准日期 | 产品号批准日期 | 申请人 | 市场状态 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OCTREOTIDE ACETATE | 204669 | 001 | ANDA | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.05MG BASE/ML | No | No | 2018/12/27 | 2018/12/27 | HERITAGE PHARMS | Prescription |
| OCTREOTIDE ACETATE | 204669 | 002 | ANDA | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.1MG BASE/ML | No | No | 2018/12/27 | 2018/12/27 | HERITAGE PHARMS | Prescription |
| OCTREOTIDE ACETATE | 204669 | 003 | ANDA | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.5MG BASE/ML | No | No | 2018/12/27 | 2018/12/27 | HERITAGE PHARMS | Prescription |
| OCTREOTIDE ACETATE | 216807 | 001 | ANDA | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.2MG BASE/ML | No | No | 2023/06/13 | 2023/06/13 | GLAND PHARMA LTD | Prescription |
| OCTREOTIDE ACETATE | 216807 | 002 | ANDA | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 1MG BASE/ML | No | No | 2023/06/13 | 2023/06/13 | GLAND PHARMA LTD | Prescription |
| OCTREOTIDE ACETATE | 216839 | 001 | ANDA | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.5MG BASE/ML | No | No | 2023/06/22 | 2023/06/22 | GLAND PHARMA LTD | Prescription |
| OCTREOTIDE ACETATE | 216839 | 002 | ANDA | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 0.1MG BASE/ML | No | No | 2023/06/22 | 2023/06/22 | GLAND PHARMA LTD | Prescription |
| OCTREOTIDE ACETATE | 210317 | 001 | ANDA | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 10MG BASE/VIAL | No | No | 2023/12/05 | 2023/12/05 | TEVA PHARMS USA INC | Prescription |
| OCTREOTIDE ACETATE | 210317 | 002 | ANDA | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 20MG BASE/VIAL | No | No | 2023/12/05 | 2023/12/05 | TEVA PHARMS USA INC | Prescription |
| OCTREOTIDE ACETATE | 210317 | 003 | ANDA | OCTREOTIDE ACETATE | INJECTABLE;INJECTION | EQ 30MG BASE/VIAL | No | No | 2023/12/05 | 2023/12/05 | TEVA PHARMS USA INC | Prescription |